Post-Market Clinical Follow-up Registry to Evaluate the Safety and Performance of the HL 40 Heart Lung Machine and the Temperature Probes in Patients Undergoing Cardiac / Thoracic / Vascular Surgery
The HeaLMe post-market clinical follow-up registry is undertaken to evaluate the safety and performance of the index devices Heart Lung Machine HL 40 and Temperature Probes TPO-D-HLM L1.8 Adult / Pediatric in patients undergoing cardiac / thoracic / vascular surgery.
Feasibility Study of a Pre-hospital Extra-corporeal Membrane Oxygenation (ECMO) Capable Advanced Resuscitation Team at Achieving Blood Flow Within 30 Minutes in Patients With Refractory Cardiac Arrest.
To establish whether a pre-hospital advanced physician/ paramedic cardiac arrest team that is ECMO capable can establish ECMO flow within 30 minutes of collapse. The Sub30 study will investigate the technical and logistical feasibility of instituting pre-hospital Extracorporeal Cardiopulmonary Resuscitation (ECPR) within 30 minutes of collapse for selected patients (n=6) in a geographical sector of Greater London. It will achieve this through a unique collaboration between the primary emergency dispatch and response services (London Ambulance Service NHS Trust, LAS), pre-hospital practitioners (LAS and London Air Ambulance) and clinicians in ECMO (Barts Health NHS Trust).
Extracorporeal Membrane Oxygenation(ECMO) for Severe Acute Respiratory Distress Syndrome (ARDS)
This international multicenter, randomized, open trial will evaluate the impact of Extracorporeal Membrane Oxygenation (ECMO), instituted early after the diagnosis of acute respiratory distress syndrome (ARDS) not evolving favorably after 3-6 hours under optimal ventilatory management and maximum medical treatment, on the morbidity and mortality associated with this disease.
100 项与 Maquet Cardiopulmonary GmbH 相关的临床结果
0 项与 Maquet Cardiopulmonary GmbH 相关的专利(医药)
迈柯唯(上海)医疗设备有限公司报告,由于斯洛伐克、保加利亚、克罗地亚及立陶宛的5台HCU40未提供当地语言版本的说明书的原因。生产商迈柯唯心肺医疗有限责任公司Maquet Cardiopulmonary GmbH 对其生产的心肺转流热交换水箱Heater-Cooler Unit(国械注进20182451979)主动召回。召回级别为三级召回。涉及产品的型号、规格及批次等详细信息见《医疗器械召回事件报告表》。 附件:医疗器械召回事件报告表 2023年12月28日迈柯唯(上海)医疗设备有限公司召回报表.pdf
迈柯唯(上海)医疗设备有限公司报告,由于涉及特定型号、特定批次产品,存在漏电风险,生产商迈柯唯心肺医疗有限责任公司 Maquet Cardiopulmonary GmbH 对医用物理升温仪(注册证编号:国械注进20162451786)主动召回。召回级别为二级。涉及产品的型号、规格及批次等详细信息见《医疗器械召回事件报告表》。 附件:医疗器械召回事件报告表 2023年1月31日迈柯唯(上海)医疗设备有限公司附件.pdf
100 项与 Maquet Cardiopulmonary GmbH 相关的药物交易
100 项与 Maquet Cardiopulmonary GmbH 相关的转化医学